Xu et al. further reported that poliumoside counteracts HGHF-induced bone degradation and ferroptosis by activating the NRF2/GPX4 signaling pathway, suggesting its potential as a novel therapeutic approach for T2DM-associated osteoporosis [176]. The gene discussed is NFE2L2; the disease is type 2 diabetes mellitus.